Gary Kleiger (Chemistry) participated in an international collaboration with Brenda Schulman, director of the Max Planck Institute of Biochemistry. Published this week in Nature, . How these enzymes work is also of considerable importance to a blossoming, new drug discovery area in biotechnology called targeted protein degration.
